SORN:NASDAQSoren Acquisition Corp. Analysis
Data as of 2026-05-02 - not real-time
$9.90
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The 20‑day SMA is essentially level with the 200‑day SMA, and the RSI hovers near the midpoint, suggesting a neutral to mildly bullish stance. However, the MACD histogram is negative and the MACD signal is bearish, tempering the bullish bias. Volume is on an upward trend, and the price is trading just above a modest support level while approaching a nearby resistance.
Fundamental and market context: Soren Acquisition Corp. remains a shell with no operating revenue, earnings, or cash, and carries substantial debt relative to an equity base that is effectively negative. The price‑to‑book ratio is deeply negative, and there is no dividend. The broader market sentiment is in an “Extreme Greed” phase, which may be inflating speculative SPAC valuations despite the lack of intrinsic financials.
Fundamental and market context: Soren Acquisition Corp. remains a shell with no operating revenue, earnings, or cash, and carries substantial debt relative to an equity base that is effectively negative. The price‑to‑book ratio is deeply negative, and there is no dividend. The broader market sentiment is in an “Extreme Greed” phase, which may be inflating speculative SPAC valuations despite the lack of intrinsic financials.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with limited upside before resistance
- Bearish MACD signal despite rising volume
- Heavy debt load with no operating cash
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential acquisition target could unlock value
- Bullish trend direction indicated by SMA alignment
- Increasing volume suggests market interest
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- SPAC structure carries high execution risk
- Successful merger could provide significant upside
- Absence of earnings, cash, and tangible assets limits intrinsic value
Key Metrics & Analysis
Financial Health
Debt/Equity153.62
P/B Ratio-1237.5
Industry P/E17.5
Technical Analysis
TrendBullish
RSI51.7
Support$9.86
Resistance$9.94
MA 20$9.90
MA 200$9.88
MACDBearish
VolumeIncreasing
Fear & Greed Index91.09
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.03
Volatility4.36%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.